COVID 19 Data Forum - 2021-03-18

During the Virtual useR! 2020 Conference, the R Consortium hosted a series of talks presented by Jenna Reps, Manager of Epidemiology Analytics and Janssen Research and Development, Andrea Ganna, EMBL group leader at FIMM, and Kenneth L Massey, Vice President of U.S Medical Affairs at Merck on several COVID19 Data analysis. Jenna Reps began the presentation on the OHDSI Approach on Making Covid-19 Clinical Data available. Jenna began by giving some background on the data gathered and the data model v5.3. From this, she continued to explain how the study conducted by OHDSI was lead and best practices for leading a study. She then continued the presentation by sharing the three main areas of interest which included, Clinical characterization, patient-level predictions, and population-level effect estimation. Following, Jenna also shared some covid-19 study examples. To conclude, Jenna shared various ways to contribute and other resources.

Andrea Ganna then followed with his presentation on the Covid Host Genetics Initiative. Andrea began by sharing about the COVID-19 HGI, its code of conduct, numbers, and resources, along with ways to share data. Andrea continued with the future of COVID19-HGI and shared goals for the study. To close, Andrea gave some acknowledgments for those who have contributed to the project and other resources for people to join. The final third presentation was presented by Kenneth L Massey of the EndPandemic National Data Consortium. Kenneth began the presentation by sharing some background information, the challenge of the study, and goals for EndPandemic. After, he shared about Saama’s life science Analytical cloud (LSAC) and more on the overall project including command center information. He concluded the presentation by sharing about dimensions of epidemiology data and sharing a take-home message. The presentation was followed by a questions and answers session with all the presenters. Finally, the webinar concluded with some closing remarks and thank you.

This video is part of the virtual useR! 2020 conference.

Main Sections

0:00 Introduction
3:58 Making covid-19 clinical data available – The OHDSI approach, Jenna Reps
5:20 OMOP Common Data model v5.3
7:11 The OHDSI way
10:24 Everyone can lead a study
12:28 Main areas of interest
13:31 Covid-19 examples
16:56 Want to contribute?
17:11 Conclusion and questions
20:11 The Covid host genetics initiative, Andrea Ganna
21:46 The COVID19-HGI aims and code of conduct
23:27 Registration study
26:00 The COVID19-HGI in numbers
27:22 The COVID19-HGI resources
28:14 The COVID19-HGI - how to share data
34:22 In-sillico follow up
35:17 The COVID19-HGI future direction
36:02 Acknowledgements and questions
38:26 EndPandemic National data consortium- Kenneth L Massey, PharmD
40:34 The challenge
42:19 Goals of endPANDEMIC National Data Consortium
44:03 Saama’s life science Analytical cloud (LSAC)
48:31 Aggregate all patient data
50:55 Command center information structure
52:34 The COVID19 Command center can accelerate the fight
54:03 Questions and closing
55:43 Covid-19 Clinical data: promises and pitfalls
1:00:42 Data streams and severity pyramid
1:04:52 Dimensions of epidemiology data
1:12:05 Take home messages
1:13:37 Panel questions
1:39:32 Thank you!



More Resources